share_log

永泰生物-B:建議根據一般授權發行可換股債券 及 一名主要股東訂立股份認購權契據

Immunotech Biopharm Ltd-B: PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE AND CALL OPTION DEED BY A SUBSTANTIAL SHAREHOLDER

Oct 30, 2022 07:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more